title: [Function and structure of the Federal Joint Committee and the Institute for Quality and Efficiency in Health Care in consideration of patient involvement].
abstract: The Federal Joint Committee and the Institute for Quality and Efficiency in Health Care have become important players in the German health care system, not only since the benefit assessment of pharmaceuticals and the Act on the Reform of the Market for Medicinal Products (AMNOG) were established. However, the manifold tasks and duties these institutions have besides the benefit assessment of pharmaceuticals is less known, just as the role the patient's representatives play. The function and structure of the Federal Joint Committee and the Institute for Quality and Efficiency in Health Care as well as their collaboration in consideration of patient involvement will be explained in this article.
authors.affiliation: Institut für Klinische Pharmakologie der Technischen Universität Dresden.
authors.forename: V
authors.initials: V
authors.lastname: Mühlbauer
authors.affiliation: Referentin Stabsstelle Patientenbeteiligung, Gemeinsamer Bundesausschuss, Berlin.
authors.forename: S
authors.initials: S
authors.lastname: Teupen
mesh_terms: D026683:Advisory Committees / Q000191:economics* / Q000458:organization & administration*; D003299:Cooperative Behavior; D003362:Cost-Benefit Analysis / Q000191:economics; D017598:Efficiency, Organizational / Q000191:economics* / Q000592:standards*; D005858:Germany; D006298:Health Services Administration / Q000191:economics* / Q000592:standards*; D006801:Humans; D033183:Interdisciplinary Communication; D009313:National Health Programs / Q000191:economics* / Q000458:organization & administration*; D010358:Patient Participation / Q000191:economics* / Q000379:methods*; D011787:Quality of Health Care / Q000191:economics* / Q000458:organization & administration*